Home/Filings/4/0001127602-21-015360
4//SEC Filing

Johnston Lori A 4

Accession 0001127602-21-015360

CIK 0000318154other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 7:31 PM ET

Size

11.0 KB

Accession

0001127602-21-015360

Insider Transaction Report

Form 4
Period: 2021-04-30
Transactions
  • Tax Payment

    Common Stock

    2021-05-01$239.64/sh355$85,07237,700 total
  • Tax Payment

    Common Stock

    2021-05-03$239.64/sh335$80,27937,365 total
  • Award

    Nqso (Right to Buy)

    2021-04-30+28,62328,623 total
    Exercise: $239.64From: 2023-04-30Exp: 2031-04-30Common Stock (28,623 underlying)
  • Award

    Common Stock

    2021-04-30+3,29638,055 total
Footnotes (4)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively.
  • [F2]These shares include the following RSUs granted under the Company's equity plans: 690 RSUs which will vest on 4/27/2022; 1,361 RSUs which will vest in installments of 670 on 5/3/2022 and 691 on 5/3/2023; 7,799 RSUs which will vest in installments of 2,573 on 11/1/2021, 2,574 on 11/1/2022 and 2,652 on 11/1/2023; 2,961 RSUs which vest in two installments of 977 on 5/5/2022 and 5/5/2023, and one installment of 1,007 on 5/5/2024; and 3,296 RSUs which vest in installments of 1,087 on 4/30/2023, 1,088 on 04/30/2024 and 1,121 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F3]These shares include 564 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  • [F4]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001558616

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 7:31 PM ET
Size
11.0 KB